Sykon Capital’s Pfizer PFE Stock Holding History

Sykon Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$337K	Hold	14,014	–	–	0.1%	81
2026 Q1	$394K	Hold	14,014	–	–	0.13%	62
2025 Q4	$349K	Hold	14,014	–	–	0.11%	94
2025 Q3	$357K	Buy	14,014 +2,000	+17%	+$49.4K	0.12%	84
2025 Q2	$291K	Hold	12,014	–	–	0.11%	69
2025 Q1	$304K	Hold	12,014	–	–	0.12%	50
2024 Q4	$319K	Hold	12,014	–	–	0.11%	51
2024 Q3	$348K	Hold	12,014	–	–	0.12%	72
2024 Q2	$336K	Hold	12,014	–	–	0.13%	67
2024 Q1	$333K	Hold	12,014	–	–	0.12%	77
2023 Q4	$346K	Hold	12,014	–	–	0.14%	62
2023 Q3	$399K	Sell	12,014 -691	-5%	-$24.4K	0.17%	38
2023 Q2	$466K	Buy	+12,705	New	+$495K	0.32%	33

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sykon Capital's PFE Position: Q2 2026 in Review

Sykon Capital held its Pfizer (PFE) position steady in Q2 2026 at 14,014 shares worth $337K. The position accounts for 0.1% of the portfolio, ranked #81.

Sykon Capital first reported a position in PFE in Q2 2023 and has held it in 13 quarters since. The position peaked at $466K in Q2 2023. 2,835 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Sykon Capital held 14,014 shares of Pfizer worth $337K as of Q2 2026.
Sykon Capital left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.1% of Sykon Capital's portfolio in Q2 2026, its #81 holding.
Sykon Capital first reported a position in Pfizer in Q2 2023 and has held it in 13 quarters since.
Sykon Capital's Pfizer position peaked at $466K in Q2 2023.
2,835 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sykon Capital's 13F filing for Q2 2026, filed 12 Aug 2026.